133 related articles for article (PubMed ID: 35797633)
41. Summary: Appropriate Use Criteria for Estrogen Receptor-Targeted PET Imaging with 16α-
Ulaner GA; Mankoff DA; Clark AS; Fowler AM; Linden HM; Peterson LM; Dehdashti F; Kurland BF; Mortimer J; Mouabbi J; Moon DH; de Vries EGE
J Nucl Med; 2023 Mar; 64(3):351-354. PubMed ID: 36863779
[TBL] [Abstract][Full Text] [Related]
42. Discrepancy between [18F]-FES and [18F]-FDG PET/CT in ER-positive breast cancer with oesophageal metastasis.
Kiatkittikul P; Promteangtrong C; Kunawudhi A; Siripongsatian D; Chotipanich C
Eur J Nucl Med Mol Imaging; 2022 Jul; 49(9):3297-3298. PubMed ID: 35362795
[No Abstract] [Full Text] [Related]
43. 18F-Fluoroestradiol Tumor Uptake Is Influenced by Structural Components in Breast Cancer.
Takahashi M; Maeda H; Tsujikawa T; Kono H; Mori T; Kiyono Y; Okazawa H; Noriki S; Imamura Y; Goi T
Clin Nucl Med; 2021 Nov; 46(11):884-889. PubMed ID: 34319950
[TBL] [Abstract][Full Text] [Related]
44. To Identify Small Bowel Metastasis From Lobular Breast Cancer on 18 F-Fluoroestradiol PET/CT : Necessary to Adjust the Background Uptake Level.
Lu Y
Clin Nucl Med; 2023 Feb; 48(2):192-193. PubMed ID: 36083216
[TBL] [Abstract][Full Text] [Related]
45. Molecular Imaging Assessment of Hormonally Sensitive Breast Cancer: An Appraisal of 2-[18F]-Fluoro-2-Deoxy-Glucose and Newer Non-2-[18F]-Fluoro-2-Deoxy-Glucose PET Tracers.
Yadav D; Kumar R; Phulia A; Basu S; Alavi A
PET Clin; 2022 Jul; 17(3):399-413. PubMed ID: 35717099
[TBL] [Abstract][Full Text] [Related]
46. Brain 18F-choline PET/CT in primary diffuse leptomeningeal melanomatosis.
Jacob M; Delfort F; Heliette C; Renard D
Acta Neurol Belg; 2016 Dec; 116(4):647-648. PubMed ID: 27085711
[No Abstract] [Full Text] [Related]
47. 68Ga-DOTATOC PET/CT and MR in the Evaluation of Meningeal Metastasis From Esthesioneuroblastoma: A Case Report.
Dondi F; Albano D; Bertoli M; Bertagna F; Giubbini R
Clin Nucl Med; 2021 Jul; 46(7):e378-e380. PubMed ID: 33782294
[TBL] [Abstract][Full Text] [Related]
48. Comparative breast tumor imaging and comparative in vitro metabolism of 16alpha-[18F]fluoroestradiol-17beta and 16beta-[18F]fluoromoxestrol in isolated hepatocytes.
Jonson SD; Bonasera TA; Dehdashti F; Cristel ME; Katzenellenbogen JA; Welch MJ
Nucl Med Biol; 1999 Jan; 26(1):123-30. PubMed ID: 10096512
[TBL] [Abstract][Full Text] [Related]
49. 18F-labeled difluoroestradiols: preparation and preclinical evaluation as estrogen receptor-binding radiopharmaceuticals.
Seimbille Y; Rousseau J; Bénard F; Morin C; Ali H; Avvakumov G; Hammond GL; van Lier JE
Steroids; 2002 Aug; 67(9):765-75. PubMed ID: 12123788
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of tumour heterogeneity by
Liu C; Hu S; Xu X; Zhang Y; Wang B; Song S; Yang Z
Breast Cancer Res; 2022 Aug; 24(1):57. PubMed ID: 36028895
[TBL] [Abstract][Full Text] [Related]
51. PET Imaging of Estrogen Receptors for Gynecological Tumors.
Tsujikawa T; Makino A; Mori T; Tsuyoshi H; Kiyono Y; Yoshida Y; Okazawa H
Clin Nucl Med; 2022 Jul; 47(7):e481-e488. PubMed ID: 35675139
[TBL] [Abstract][Full Text] [Related]
52. 18F-Fluoroestradiol PET in the evaluation of probable oligometastatic breast cancer.
Denton M; Taubman K; Sutherland T
J Med Imaging Radiat Oncol; 2021 Jun; 65(3):333-334. PubMed ID: 33369181
[TBL] [Abstract][Full Text] [Related]
53. Cross-Species Physiological Assessment of Brain Estrogen Receptor Expression Using
Paquette M; Phoenix S; Lavallée É; Rousseau JA; Guérin B; Turcotte ÉE; Lecomte R
Mol Imaging Biol; 2020 Oct; 22(5):1403-1413. PubMed ID: 32699974
[TBL] [Abstract][Full Text] [Related]
54. MRI based neuroanatomical segmentation in breast cancer patients: leptomeningeal carcinomatosis vs. oligometastatic brain disease vs. multimetastastic brain disease.
Mayinger M; Reibelt A; Borm KJ; Ettl J; Wilkens JJ; Combs SE; Oechsner M; Duma MN
Radiat Oncol; 2019 Sep; 14(1):170. PubMed ID: 31533742
[TBL] [Abstract][Full Text] [Related]
55. Systemic and cerebral kinetics of 16 alpha [18F]fluoro-17 beta-estradiol: a ligand for the in vivo assessment of estrogen receptor binding parameters.
Moresco RM; Casati R; Lucignani G; Carpinelli A; Schmidt K; Todde S; Colombo F; Fazio F
J Cereb Blood Flow Metab; 1995 Mar; 15(2):301-11. PubMed ID: 7860663
[TBL] [Abstract][Full Text] [Related]
56. Leptomeningeal Metastasis in Carotid Body Paraganglioma: Findings on 68Ga DOTANOC PET-CT.
Tripathy S; Damle NA; Naranje P; Shamim SA; Tripathi M; Bal C
Clin Nucl Med; 2019 Oct; 44(10):e583-e585. PubMed ID: 31348087
[TBL] [Abstract][Full Text] [Related]
57. Can
Gupta M; Datta A; Choudhury PS; Dsouza M; Batra U; Mishra A
World J Nucl Med; 2017; 16(2):133-139. PubMed ID: 28553180
[TBL] [Abstract][Full Text] [Related]
58. Demonstration of in vivo estrogen receptor status with 16α- [
Has Simsek D; Kuyumcu S; Ozkan ZG; Vuralli Bakkaloglu D; Bayram A; Topuz S; Aydıner A; Sanli Y
Eur J Nucl Med Mol Imaging; 2021 Nov; 48(12):4101-4102. PubMed ID: 34031720
[No Abstract] [Full Text] [Related]
59. Positron tomographic assessment of 16 alpha-[18F] fluoro-17 beta-estradiol uptake in metastatic breast carcinoma.
McGuire AH; Dehdashti F; Siegel BA; Lyss AP; Brodack JW; Mathias CJ; Mintun MA; Katzenellenbogen JA; Welch MJ
J Nucl Med; 1991 Aug; 32(8):1526-31. PubMed ID: 1869973
[TBL] [Abstract][Full Text] [Related]
60.
Kumar M; Salem K; Michel C; Jeffery JJ; Yan Y; Fowler AM
J Nucl Med; 2019 Sep; 60(9):1247-1252. PubMed ID: 30850489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
